Role of apoptosis in sarcopenia.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and pre-clinical evidence without systematic methodology
PubMed 14630880 · doi:10.1093/gerona/58.11.m999
What was done
This narrative review summarizes literature regarding the role of apoptotic signaling pathways—including mitochondrial-mediated, receptor-mediated, and sarcoplasmic-reticulum-mediated pathways converging on caspase-3—in age-related muscle loss and sarcopenia across human and rodent studies.
What was found
The authors report that by age 80, humans typically lose 30% to 40% of skeletal muscle fibers, predominantly type II fibers such as in the vastus lateralis, while rodent models demonstrate a 20% to 50% fiber loss depending on muscle type. Age-related increases in caspase levels (such as caspase-3) are cited as potential contributors to nuclear loss, protein degradation, and myocyte death.
Why it matters
It provides a mechanistic overview of how programmed cell death cascades may drive the cellular and myofiber loss characteristic of sarcopenia in aging.
Limits
The abstract describes a non-systematic narrative review rather than a primary clinical study or systematic review. It does not provide sample sizes, quantitative pooled analyses, effect sizes, or direct causal evidence in human clinical trials.
Cited by
- supports In aging and sarcopenia, type 1 muscle fibers are relatively preserved while type 2 muscle fibers experience preferential atrophy and loss through apoptosis.